Literature DB >> 21968509

Investigation on the micelle-sensitized Ce(IV)-lornoxicam-Rh B chemiluminescence system and its application.

Fang Zhao1, Wenhui Zhao.   

Abstract

Based on the micelle synergism mechanism, a simple and sensitive flow injection chemiluminescence (FI-CL) method for the assay of lornoxicam was described. The CL signal generated from the reaction of Ce (IV) with lornoxicam in acidic solution was very weak, while the interfusion of sodium dodecyl benzene sulfonate (SDBS) resulted in a highly CL intensity. Under the optimum experimental conditions, the CL intensity was proportional to lornoxicam concentration over the range 1.0 × 10(-10)-7.3 × 10(-8) g/mL with a detection limit of 4.9 × 10(-11) g/mL (3σ). The relative standard deviation for 11 replicate measurements of 3.0 × 10(-9) g/mL of lornoxicam was 1.9%. The proposed method was successfully applied for the assay of lornoxicam in pharmaceuticals, human serum and urine with excellent recovery. The possible mechanism of CL reaction was also discussed briefly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21968509     DOI: 10.1007/s10895-011-0987-z

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  22 in total

1.  Square-wave adsorptive stripping voltammetric determination of the anti-inflammatory drug lornoxicam.

Authors:  M M Ghoneim; A M Beltagi; A Radi
Journal:  Anal Sci       Date:  2002-02       Impact factor: 2.081

2.  Acidic potassium permanganate as a chemiluminescence reagent--a review.

Authors:  Jacqui L Adcock; Paul S Francis; Neil W Barnett
Journal:  Anal Chim Acta       Date:  2007-08-23       Impact factor: 6.558

Review 3.  Recent applications of flow-injection and sequential-injection analysis techniques to chemiluminescence determination of pharmaceuticals.

Authors:  Katerina Mervartová; Miroslav Polásek; José Martínez Calatayud
Journal:  J Pharm Biomed Anal       Date:  2007-08-21       Impact factor: 3.935

4.  Determination of lornoxicam in pharmaceutical preparations by zero and first order derivative UV spectrophotometric methods.

Authors:  E Nemutlu; S Demircan; S Kir
Journal:  Pharmazie       Date:  2005-06       Impact factor: 1.267

5.  Simultaneous high-performance liquid chromatographic determination of lornoxicam and its 5'-hydroxy metabolite in human plasma using electrochemical detection.

Authors:  T Suwa; H Urano; Y Shinohara; J Kokatsu
Journal:  J Chromatogr       Date:  1993-07-23

6.  Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl).

Authors:  Elham Anwer Taha; Nahla Nour Salama; Laila El-Sayed Abdel Fattah
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-05       Impact factor: 1.645

Review 7.  Anti-inflammatory drugs and their mechanism of action.

Authors:  J R Vane; R M Botting
Journal:  Inflamm Res       Date:  1998-10       Impact factor: 4.575

8.  Liquid chromatography-electrospray ionization tandem mass spectrometric determination of lornoxicam in human plasma.

Authors:  Young Hoon Kim; Hye Young Ji; Eun-Seok Park; Soo-Wan Chae; Hye Suk Lee
Journal:  Arch Pharm Res       Date:  2007-07       Impact factor: 4.946

Review 9.  Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.

Authors:  N M Skjodt; N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

10.  Rapid rp HPLC method for quantitative determination of lornoxicam in tablets.

Authors:  Mahesh Attimarad
Journal:  J Basic Clin Pharm       Date:  2010-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.